Michael Jaffee is a Neurology physician affiliated with University of Florida. OpenAlex indexes 129 publications with 2,400 citations (h-index 26); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2000 SW Archer Rd
Gainesville, FL 326081136
Telephone
352-273-5550Registry record last updated 9 May 2016.
Clinical trials
- Sertraline vs. Placebo for Symptoms Following Traumatic Brain Injury
Sponsor: Walter Reed Army Medical Center
- Treatment of Citalopram for Anxiety Disorders Following a Traumatic Brain Injury
Sponsor: Walter Reed Army Medical Center
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Heron Therapeutics, Inc.Program year20222 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
100%SSRI36.1%Trazodone Hcl56%Escitalopram Oxalate44%Part D<11 patientsN-methyl-D-aspartate Receptor Antagonist28.6%Memantine Hcl100%Part D<11 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
2 NIH research awards on record, funded 2021–2026 per NIH RePORTER. The latest:
- Automated Neurodegeneration Index in At-Risk Cohorts for Lewy Body Disease
University of Florida
FY2026$597,264R01AG100181
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- A wireless device for continuous measurement of brain parenchymal resistance tracks glymphatic function in humans
Nature Biomedical Engineering
2025 - Identifying progression subphenotypes of Alzheimer’s disease from large-scale electronic health records with machine learning
Journal of Biomedical Informatics
2025 - Continuous glucose monitoring and all‐cause mortality in insulin‐using population with diabetes and cognitive impairment
Diabetes Obesity and Metabolism
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Steven Dekosky, MD
University of Florida
Brian Hoh, MD
University of Florida
Frederic Kaye, MD
University of Florida
Kelly Foote, MD
University of Florida
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”